Mylan’s abbreviated new drug application for morphine sulphate extended-release tablets has been approved by the US Food and Drug Administration (FDA) .

The tablets are available in doses of 15mg, 30mg, 60mg, 100mg and 200mg.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The dose formulations are the generic equivalent to Purdue Pharma’s MS Contin, an opioid analgesic for moderate-to-severe pain management.

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Recognised with 2025 Excellence Awards for Research and Development and Marketing , Novotech converted FDA/EMA fast track designations into faster HDV trial timelines while translating complex HBV science into sponsor ready insights. Discover how this dual strength in execution and communication is reshaping liver disease clinical development.

Discover the Impact